CardioNXT

CardioNXT, Inc. is a medical device company specializing in 3D mapping and navigation systems for treating cardiac arrhythmias, particularly chronic atrial fibrillation. Founded in 2012 and based in Westminster, Colorado, the company develops the iMap System—an electromagnetic tracking and AI-enabled mapping platform that integrates with leading catheter technologies from Boston Scientific, Medtronic, and Abbott, as well as CardioNXT's proprietary MultiLink CS Catheter. The iMap System supports next-generation pulsed field ablation (PFA) navigation with advanced features including contact detection, customized lesion tagging, and field scaling capabilities. CardioNXT enables zero-fluoroscopy 3D mapping procedures, reducing radiation exposure during cardiac electrophysiology interventions. The company has received FDA 510(k) clearance and holds seven patents in cardiac mapping and navigation technology.